Please assess the completion status of the following clinical trial:

Trial Title: Effects of Helicobacter Pylori Infection Eradication in Patients With Parkinson's Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of idiopathic Parkinson's disease (PD) by a neurologist~* Age more than 18 years~* Written informed consent given either by the patient or next of kin~* Patient on L-DOPA therapy~Exclusion Criteria:~* Patients with a diagnosis of secondary parkinsonism, and Parkinson's plus syndrome~* History of recent proton pump inhibitors (PPIs) or Histamine (H2) antagonist use for at least 4 weeks prior to the urea breath test~* History of recent antibiotics use (less than 6 months)~* Inability to perform urea breath test

- Gender: ALL
- Minimum Age: 17 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Eradication therapy (Type: EXPERIMENTAL): The patients who were positive for H.pylori infection are entered into an eradication therapy protocol which includes oral esomeprazole 40mg daily, oral clarithromycin 500mg bd and oral amoxicillin 1000mg bd for 14 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).